The Kaplan–Meier survival curves, including the number of elevated biomarkers, showed that patients with both GDF-15 and NT-pro BNP levels above the cut-off point had a significantly higher risk of death or HF rehospitalization at each of the three time points than patients with only one or no elevated biomarkers. The gene discussed is NPPB; the disease is hydrops fetalis.